Ben Ke

11PUBLICATIONS
8CO-AUTHORS
Immunogenetics (incl. genetic immunology)Haematological tumoursNanomedicineApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 12, 2026
The Efficacy and Safety of Telitacicept versus the Recommended Regimens in IgA Nephropathy: A Single-Center Experience.

|Dec 30, 2025
Yin-Yang 1/Neural Precursor Cell-Expressed Developmentally Downregulated 4-Like Axis Suppresses Mer Tyrosine Kinase-Mediated Macrophage Efferocytosis to Exacerbate Atherosclerosis Via Triggering Pyroptosis.

Qiang Liu, Zaihua Cheng, Tao Wu

|Nov 13, 2025
Targeting CD20 in Primary Membranous Nephropathy Serologically and Histologically Negative for PLA2R: Is Obinutuzumab Superior to Rituximab?

Huiling Cao, Yumei Feng, Xueting Li

|May 12, 2025
How to Choose Treatment Regimens for Idiopathic Membranous Nephropathy Patients with PLA2R-Negative: A Single-Center Retrospective Cohort Study.

Zijian Zhou, Yijing Zou, Ben Ke

|Mar 19, 2025
Peli1, regulated by m6A modification, suppresses NLRP3 inflammasome activation in atherosclerosis by inhibiting YB-1.

Qiang Liu, Lu Yan, Tao Wu

|Sep 27, 2024
APC and ZBTB2 May Mediate M2 Macrophage Infiltration to Promote the Development of Renal Fibrosis: A Bioinformatics Analysis.

Jianling Song, Ben Ke, Xiangdong Fang

Pageof 2

Frequent Collaborators

2 joint publications

Wen Shen

1 joint publications

Yunfei Liao

1 joint publications

Xiaoyan Long

1 joint publications

Jianjun Xu